Int J Heart Fail.  2021 Apr;3(2):81-105. 10.36628/ijhf.2020.0036.

Biomarkers in Acute Heart Failure: Diagnosis, Prognosis, and Treatment

• Wettersten N

• KMID: 2532587
• DOI: http://doi.org/10.36628/ijhf.2020.0036

Abstract

Heart failure is a global health problem. An episode of acute heart failure (AHF) is a period of substantial morbidity and mortality with few advances in the management of an episode that have improved outcomes. The measurement of multiple biomarkers has become an integral adjunctive tool for the management of AHF. Many biomarkers are now well established in their ability to assist with diagnosis and prognostication of an AHF patient. There are also emerging biomarkers that are showing significant promise in the areas of diagnosis and prognosis. For improving the management of AHF, both established and novel biomarkers may assist in guiding medical therapy and subsequently improving outcomes. Thus, it is important to understand the different abilities and limitations of established and emerging biomarkers in AHF so that they may be correctly interpreted and integrated into clinical practice for AHF. This knowledge may improve the care of AHF patients. This review will summarize the evidence of both established and novel biomarkers for diagnosis, prognosis and management in AHF so that the treating clinician may become more comfortable incorporating these biomarkers into clinical practice in an evidence-based manner.

Keyword

Heart failure; Biomarkers; Diagnosis; Prognosis; Therapy